about
Magnetic resonance imaging changes of sacroiliac joints in patients with recent-onset inflammatory back pain: inter-reader reliability and prevalence of abnormalitiesA tale of two cities: hospitalization costs in 1897 and 1997.Evaluation of patients with a recent clinical fracture and osteoporosis, a multidisciplinary approach.Searching for potential biomarkers that can be used as biomarkers for diagnosing ankylosing spondylitis.Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis.Large epidemiologic studies of gout: challenges in diagnosis and diagnostic criteria.Seronegative spondyloarthritides.ICF Core Sets for low back pain.How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy.Osteoporosis and vertebral fractures in ankylosing spondylitis.Issues in the treatment of ankylosing spondylitis with non-steroidal anti-inflammatory drugs.Determinants of the prevalence of gout in the general population: a systematic review and meta-regression.The ASAS Criteria for Axial Spondyloarthritis: Strengths, Weaknesses, and Proposals for a Way Forward.Association between serum uric acid, aortic, carotid and femoral stiffness among adults aged 40-75 years without and with type 2 diabetes mellitus: The Maastricht Study.Etanercept in the longterm treatment of patients with ankylosing spondylitis.COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention.Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis.Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years.Factors associated with body function and disability in patients with ankylosing spondylitis: a cross-sectional study.The Gout Assessment Questionnaire 2.0: cross-cultural translation into Dutch, aspects of validity and linking to the International Classification of Functioning, Disability and Health.Cost of illness and determinants of costs among patients with gout.The cross-sectional association between uric acid and atherosclerosis and the role of low-grade inflammation: the CODAM studyAxial Spondyloarthritis: A Better Name for an Old Disease: A Step Toward Uniform ReportingDoctor-patient interaction: standardized patients' reflections from inside the rheumatological officeA randomized clinical trial comparing fitness and biofeedback training versus basic treatment in patients with fibromyalgiaHigh or low intensity aerobic fitness training in fibromyalgia: does it matter?Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysisDetermination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable differenceReproducibility of clinical performance assessment in practice using incognito standardized patientsThe Sharp/van der Heijde method out-performed the Larsen/Scott method on the individual patient level in assessing radiographs in early rheumatoid arthritisThe relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysisWhat is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filterMeasurement of spinal mobility in ankylosing spondylitis: comparison of occiput-to-wall and tragus-to-wall distanceClinical vertebral fractures in patients with ankylosing spondylitis
P50
Q21092909-7D0C6968-A35B-4758-94F1-5DE669DFAA03Q33204019-AA68339D-A419-485D-A4B0-F17908020DDBQ33357718-BF2959FF-6F79-4D7E-AD11-474F6BBB31CFQ33579369-2B7B6D49-A438-413E-9A3B-D7BFF09CB5B6Q33844201-D9460AB9-11BE-4F31-9DDA-8299D975470EQ34975884-F6F5560F-E98C-43FE-AB65-2449A2C3349AQ35021043-96C39EBD-0186-4006-8D51-79B08B8B69C8Q35888940-883AA809-B813-4A2B-94D3-8EF1B275F299Q35953430-4569C70E-BB01-4CB8-A194-E5849DA3D950Q36178464-306ABB1E-BCAC-4528-AE1B-446A09506B34Q36507976-FCDF10B8-9DC7-47C5-98F6-291030DDAE99Q36841353-F59C22DC-DAA5-4BA3-AB6E-C2384B5AA0A4Q37171871-81EA6D8E-29EC-4B4B-8046-89C049571E05Q38234234-B5827E96-DBC1-4600-8289-1C7A464029B9Q38569186-3AB3D0A5-BC44-48B4-8BF6-C632570F265EQ41619965-8CF17173-30A8-4AD0-892A-FD440BC46532Q42619535-3077D707-4F44-456E-A6E3-2DC43608274EQ43882911-5E705299-6F8B-4F4B-8735-FEC75C5F7166Q43947707-E910422F-B5BD-411E-928F-6C9A6FAAF341Q44267136-239BF6E9-E981-4698-9B50-4B50EA9DEC6FQ44898212-F5B462F4-1720-4310-9093-B2E153FD9398Q47285208-A1A85909-6A12-4FAA-8752-DD6408A575DFQ47584258-4F341E50-7C92-4AFC-B868-DB7236E6DA9DQ48111827-F7E2CCE4-E2E4-4CCC-94C8-9B27EE0B8A18Q48535636-C9771452-776A-470A-8428-E9077922BEF3Q55163321-C388FBA4-A99B-4A80-8D08-64555B551752Q68664749-97D97B2D-DB18-47C8-B2EF-2BDEB4066237Q74508496-BC9BEB6E-9671-4F93-903F-0BFE28258D5BQ77805302-04075099-35DD-4B97-A23F-9253643438FBQ77805306-894E60C0-F6B3-43EB-9A36-46055B0DF399Q77879632-0690D0C8-6B65-426A-A9F5-7A13E8BCAF75Q77941050-F33CE798-5377-48EF-AD7F-47D8D6C48A46Q78297787-9CA19FB6-68C0-4AF5-9018-5A84366F2D73Q80199492-59141C42-C086-44EF-BB00-C3CD773B5965Q80330544-B0B2E85B-7F5D-415C-9661-05CDC3D4B94BQ80502420-62DBFCE9-93CB-42C9-ABA7-9493CFA96268Q80510028-27ADE2EB-D185-4009-AF18-150A2211FF92Q80829173-F088519A-941E-45E1-8C1F-0257FBAF9EAB
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
Sjef van der Linden
@ast
Sjef van der Linden
@en
Sjef van der Linden
@es
Sjef van der Linden
@nl
type
label
Sjef van der Linden
@ast
Sjef van der Linden
@en
Sjef van der Linden
@es
Sjef van der Linden
@nl
altLabel
J.M.J.P. van der Linden
@en
J.M.J.P. van der Linden
@nl
JMJP van der Linden
@en
JMJP van der van der Linden
@nl
S. van der Linden
@nl
prefLabel
Sjef van der Linden
@ast
Sjef van der Linden
@en
Sjef van der Linden
@es
Sjef van der Linden
@nl
P106
P19
P21
P31
P496
0000-0002-0087-0351
P569
1944-12-13T00:00:00Z